
NextCure, Inc.
NXTCHealthcare|Biotechnology|US
$5.33
+0.21 (+4.10%)
DCF Value
$6.71
Tangible Book / Share
$2.29
Cash / Share
$3.78
Next Earnings Report
Mar 4, 2027
EPS est. -$0.79
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Nov 6, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (3)
Dec 2026
Est. completion
P2Advanced Non-small Cell Lung Cancer
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
NCT04699123n=159
Feb 2028
Est. completion
P1Advanced Solid Tumors
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
NCT06792552n=738
Dec 2028
Est. completion
P2Pancreatic Cancer
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
NCT06941857n=20
Recent Press Releases
SEC Filings (79)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Nov 6, 2026 | S-4/A | DocumentIndex | |
| Nov 2, 2026 | S-4/A | DocumentIndex | |
| Oct 30, 2026 | 8-K | Material event | DocumentIndex |
| Oct 20, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 1, 2026 | S-4/A | DocumentIndex | |
| Sep 25, 2026 | 425 | DocumentIndex | |
| Sep 25, 2026 | 8-K | Material event | DocumentIndex |
| Sep 3, 2026 | 8-K | Material event | DocumentIndex |
| Aug 18, 2026 | S-4 | DocumentIndex | |
| Aug 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 10, 2026 | 425 | DocumentIndex | |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Aug 4, 2026 | 425 | DocumentIndex | |
| Jul 16, 2026 | 425 | DocumentIndex | |
| Jul 14, 2026 | 425 | DocumentIndex | |
| Jul 14, 2026 | 8-K | Material event | DocumentIndex |
| Jun 25, 2026 | 8-K | Material event | DocumentIndex |
| Jun 1, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| May 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 24, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 24, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 5, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 5, 2026 | 8-K | Material event | DocumentIndex |
| Mar 5, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 12, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 29, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 23, 2026 | 8-K | Material event | DocumentIndex |
| Dec 19, 2025 | 8-K | Material event | DocumentIndex |